Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis
Cholestasis is common in multiple clinical circumstances. The NOD-like receptor protein 3 (NLRP3) inflammasome pathway has been demonstrated to play an important role in liver injury and fibrosis induced by cholestasis. We previously proved that MCC950, a selective NLRP3 inhibitor, alleviates liver...
Saved in:
Main Authors: | Xiaopeng Wang (Author), Guiyang Wang (Author), Junwen Qu (Author), Zhiqing Yuan (Author), Ruogu Pan (Author), Kewei Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
by: Bo Wu, et al.
Published: (2022) -
JTE-013 Alleviates Pulmonary Fibrosis by Affecting the RhoA/YAP Pathway and Mitochondrial Fusion/Fission
by: Jiaxu Zhou, et al.
Published: (2023) -
The Role of Inflammation in Cholestatic Liver Injury
by: Chen J, et al.
Published: (2023) -
Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury
by: Andrea Villar-Lorenzo, et al.
Published: (2019) -
Chlorogenic acid protects against cholestatic liver injury in rats
by: Duohu Wu, et al.
Published: (2015)